Boolean network-based analysis of the apoptosis network: Irreversible apoptosis and stable surviving

Journal of Theoretical Biology

Volumn 259, Issue 4, 2009, Pages 760-769

  Mai, Zhongxing ^a   Liu, Haiyan ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Feedback loops; Irreversibility; Lethal initial states; Robustness; Signal transduction network; Stability

Indexed keywords

CASPASE 3; GROWTH FACTOR; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTIFICIAL NEURAL NETWORK; BIOLOGICAL ANALYSIS; MOLECULAR ANALYSIS; SIGNAL; STATISTICAL ANALYSIS;

APOPTOSIS; ARTICLE; CELL FATE; CELL SURVIVAL; ENZYME ACTIVATION; FEEDBACK SYSTEM; MATHEMATICAL MODEL; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SIMULATION; STATISTICAL ANALYSIS;

ANIMALS; APOPTOSIS; CELL SURVIVAL; FEEDBACK, PHYSIOLOGICAL; GROWTH SUBSTANCES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67650717307     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2009.04.024     Document Type: Article

References (55)

1. Albeck J.G., Burke J.M., et al. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30 (2008) 11-25
2. Amaral L.A.N., Diaz-Guilera A., et al. Emergence of complex dynamics in a simple model of signaling networks. Proc. Natl. Acad. Sci. USA 101 (2004) 15551-15555
3. Bagci E.Z., Vodovotz Y., et al. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J. 90 (2006) 1546-1559
4. Bentele M., Lavrik I., et al. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell Biol. 166 (2004) 839-851
5. Bernal-Mizrachi L., Lovly C.M., et al. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc. Natl. Acad. Sci. USA 103 (2006) 9220-9225
6. Budihardjo I., Oliver H., et al. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
7. Choi H.S., Han S., et al. Coupled positive feedbacks provoke slow induction plus fast switching in apoptosis. FEBS Lett. 581 (2007) 2684-2690
8. Conte D., Liston P., et al. Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc. Natl. Acad. Sci. USA 98 (2001) 5049-5054
9. De Valck D., Heyninck K., et al. A20 inhibits NF-kappaB activation independently of binding to 14-3-3 proteins. Biochem. Biophys. Res. Commun. 238 (1997) 590-594
10. Deveraux Q.L., and Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13 (1999) 239-252
11. Deveraux Q.L., Takahashi R., et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
12. Eissing T., Conzelmann H., et al. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 279 (2004) 36892-36897
13. Endo T., Abe S., et al. Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol. Immunother. 53 (2004) 770-776
14. Falschlehner C., Emmerich C.H., et al. TRAIL signalling: decisions between life and death. Int. J. Biochem. Cell Biol. 39 (2007) 1462-1475
15. Ferran C., Stroka D.M., et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91 (1998) 2249-2258
16. Ferreira C.G., van der Valk P., et al. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann. Oncol. 12 (2001) 799-805
17. Ferrell Jr. J.E. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14 (2002) 140-148
18. Ferrell J.E., and Xiong W. Bistability in cell signaling: how to make continuous processes discontinuous, and reversible processes irreversible. Chaos 11 (2001) 227-236
19. Gross A., McDonnell J.M., et al. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
20. Haupt S., Berger M., et al. Apoptosis-the p53 network. J. Cell Sci. 116 (2003) 4077-4085
21. Henson E.S., and Gibson S.B. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 18 (2006) 2089-2097
22. Hofmann H.S., Simm A., et al. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J. Cancer Res. Clin. Oncol. 128 (2002) 554-560
23. Huang S., and Ingber D.E. Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp. Cell Res. 261 (2000) 91-103
24. Janes K.A., Albeck J.G., et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 310 (2005) 1646-1653
25. Kandasamy K., and Srivastava R.K. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Cancer Res. 62 (2002) 4929-4937
26. Kauffman S. Metabolic stability and epigenesis in randomly constructed genetic nets. Theor. Biol. 22 (1969) 437-467
27. Kelliher M.A., Grimm S., et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8 (1998) 297-303
28. Kim W.H., Lee J.W., et al. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal. 17 (2005) 1516-1532
29. Ko C.H., Shen S.C., et al. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem. Pharmacol. 69 (2005) 913-927
30. Legewie S., Bluthgen N., et al. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2 (2006) e120
31. Li F., Long T., et al. The yeast cell-cycle network is robustly designed. Proc. Natl. Acad. Sci. USA 101 (2004) 4781-4786
32. Li Y., Mao Y., et al. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells. Int. J. Cancer 115 (2005) 55-64
33. Lin Y., Devin A., et al. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol. Cell Biol. 20 (2000) 6638-6645
34. Lowe S.W., Cepero E., et al. Intrinsic tumour suppression. Nature 432 (2004) 307-315
35. Mak T.W., and Yeh W.C. Signaling for survival and apoptosis in the immune system. Arthritis Res. 4 3 (2002) S243-S252
36. Morgan M.J., Thorburn J., et al. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells. Cell Death Differ. 8 (2001) 696-705
37. Muppidi J.R., Tschopp J., et al. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21 (2004) 461-465
38. Narita M., Shimizu S., et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 95 (1998) 14681-14686
39. Nemoto T., Kitagawa M., et al. Expression of IAP family proteins in esophageal cancer. Exp. Mol. Pathol. 76 (2004) 253-259
40. Nielsen-Preiss S.M., Silva S.R., et al. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. J. Cell Biochem. 90 (2003) 964-975
41. Okamura A., Iwata N., et al. Casein kinase Iepsilon down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells. Life Sci. 78 (2006) 1624-1629
42. Philchenkov A. Caspases: potential targets for regulating cell death. J. Cell Mol. Med. 8 (2004) 432-444
43. Rehm M., Huber H.J., et al. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. Embo J. 25 (2006) 4338-4349
44. Sartorius U., Schmitz I., et al. Molecular mechanisms of death-receptor-mediated apoptosis. Chem. Biochem. 2 (2001) 20-29
45. Shimizu S., Narita M., et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
46. Shu H.B., Takeuchi M., et al. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93 (1996) 13973-13978
47. Song G., Ouyang G., et al. The activation of Akt/PKB signaling pathway and cell survival. J. Cell Mol. Med. 9 (2005) 59-71
48. Stelling J. Mathematical models in microbial systems biology. Curr. Opin. Microbiol. 7 (2004) 513-518
49. Tormanen-Napankangas U., Soini Y., et al. Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int. J. Cancer 93 (2001) 192-198
50. Wang E., Marcotte R., et al. Signaling pathway for apoptosis: a racetrack for life or death. J. Cell Biochem. 32-33 Suppl (1999) 95-102
51. Wolkenhauer O. Mathematical modelling in the post-genome era: understanding genome expression and regulation-a system theoretic approach. Biosystems 65 (2002) 1-18
52. Wu C.J., Conze D.B., et al. TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. Embo J. 24 (2005) 1886-1898
53. Yan X., Fraser M., et al. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol. Oncol. 102 (2006) 348-355
54. Yu J., and Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331 (2005) 851-858
55. Zhang Z., Ma J., et al. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Ann. Thorac. Surg. 82 (2006) 243-248